Anzeige
Meldung des Tages: Straße von Hormus wieder im Fokus - und warum Permian-Barrels jetzt noch wertvoller sind

AN2 Therapeutics News

Aktie
WKN:  A3DKYC ISIN:  US0373261058 US-Symbol:  ANTX Branche:  Biotechnologie Land:  USA
3,60 $
-0,01 $
-0,28%
3,0559 € 20.04.26
Depot/Watchlist
Marktkapitalisierung *
28,80 Mio. €
Streubesitz
35,25%
KGV
-1,01
Index-Zuordnung
-

AN2 Therapeutics News

31.03.26 - Businesswire
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-​stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today ...
17.03.26 - Businesswire
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from ...
09.03.26 - Businesswire
AN2 Therapeutics Announces $40 Million Private Placement Financing
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-​stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today ...
03.03.26 - Businesswire
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV)
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-​stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today ...
17.02.26 - Businesswire
AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...

Newssuche

Videos

newspaper
20.04.26 -0,08%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »